VIEMED HEALTHCARE, INC.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
VMD$8.95-2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders' Equity
VIEMED HEALTHCARE, INC.CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Expressed in thousands of U.S. Dollars, except share and per share amounts)
| Common Stock · Additional paid-in capital · Noncontrolling interest in subsidiary · Total Shareholders'equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Retained earnings | |||||||||||
| Shareholders' equity December 31, 2022 | 38,049,739 | $15,123 | $12,125 | $69,846 | $— | $97,094 | |||||
| Stock-based compensation - options | — | — | 1,165 | — | — | 1,165 | |||||
| Stock-based compensation - restricted stock | — | — | 4,684 | — | — | 4,684 | |||||
| Exercise of options | 246,022 | 1,303 | — | — | — | 1,303 | |||||
| Shares issued for vesting of restricted stock units | 285,635 | 2,276 | (2,276) | — | — | — | |||||
| Shares redeemed to pay income tax | (75,235) | — | — | (594) | — | (594) | |||||
| Net income | — | — | — | 10,243 | — | 10,243 | |||||
| Shareholders' equity, December 31, 2023 | 38,506,161 | $18,702 | $15,698 | $79,495 | $— | $113,895 | |||||
| Stock-based compensation - options | — | — | 269 | — | — | 269 | |||||
| Stock-based compensation - restricted stock | — | — | 6,016 | — | — | 6,016 | |||||
| Exercise of options | 281,121 | 1,017 | — | — | — | 1,017 | |||||
| Shares issued for vesting of restricted stock units | 488,600 | 3,646 | (3,646) | — | — | — | |||||
| Shares redeemed to pay income tax | (142,985) | — | — | (1,069) | — | (1,069) | |||||
| Acquired non-controlling interest | — | — | — | — | 1,800 | 1,800 | |||||
| Distribution to non-controlling interest | — | — | — | — | (36) | (36) | |||||
| Net income | — | — | — | 11,265 | 144 | 11,409 | |||||
| Shareholders' equity, December 31, 2024 | 39,132,897 | $23,365 | $18,337 | $89,691 | $1,908 | $133,301 | |||||
| Stock-based compensation - options | — | — | 25 | — | — | 25 | |||||
| Stock-based compensation - restricted stock | — | — | 9,107 | — | — | 9,107 | |||||
| Exercise of options | 352,823 | 1,439 | — | — | — | 1,439 | |||||
| Shares issued for vesting of restricted stock units | 724,371 | 5,765 | (5,765) | — | — | — | |||||
| Shares redeemed to pay income tax | (214,568) | — | — | (1,734) | — | (1,734) | |||||
| Distribution to non-controlling interest | — | — | — | — | (374) | (374) | |||||
| Shares repurchased under the share repurchase program | (1,976,441) | (13,657) | 38 | — | — | (13,619) | |||||
| Net income | — | — | — | 14,934 | 442 | 15,376 | |||||
| Shareholders' equity, December 31, 2025 | 38,019,082 | $16,912 | $21,742 | $102,891 | $1,976 | $143,521 | |||||
| See accompanying notes to the consolidated financial statements | |
|---|---|
| Page | F-6 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.